IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.

Míreanna Comhchosúla

• IgG2 Antibodies against a Clinical Grade Plasmodium falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice
  le: Schwenk, Robert, et al.
  Foilsithe: (2014)
• Transgenic Parasites Stably Expressing Full-Length Plasmodium falciparum Circumsporozoite Protein as a Model for Vaccine Down-Selection in Mice Using Sterile Protection as an Endpoint
  le: Porter, Michael D., et al.
  Foilsithe: (2013)
• Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses
  le: Khan, Farhat, et al.
  Foilsithe: (2015)
• In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
  le: Livingstone, Merricka C., et al.
  Foilsithe: (2021)
• A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.
  le: Nathan Beutler, et al.
  Foilsithe: (2022-03-01)